Literature DB >> 30393767

Postoperative atrial fibrillation after cesarean delivery.

Arun Kalava1, Abby M Pribish1.   

Abstract

BACKGROUND AND AIMS: Atrial fibrillation (AF) is the most common arrhythmia seen clinically. Due to the lack of literature and guidelines on maternal AF as a postoperative complication following cesarean delivery (CD), we undertook a study to characterize parturients who developed AF following CD and to evaluate arrhythmia management and outcomes in this patient population.
METHODS: After receiving ethics committee approval, a retrospective chart review was performed to determine the incidence, possible risk factors, treatment, and outcome of women who developed AF following CD performed between 2003 and 2012 at New York Methodist Hospital in Brooklyn, New York.
RESULTS: A total of 17,039 CDs were performed at New York Methodist Hospital from 2003 to 2012. Of these, seven parturients developed AF after CD. The incidence of AF following CD in this patient population was 1:2,434 (0.04%). The age range was 26-41 years, with a median of 33 years. All 7 parturients were at term or postterm. Two deliveries were elective and five were emergent. Two of the seven parturients had prior history of paroxysmal AF. One patient was identified as having mitral regurgitation. All seven had low levels of serum magnesium postoperatively. Out of the seven, two parturients had spontaneous conversion to normal sinus rhythm, one required electrical cardioversion and four required pharmacologic cardioversion.
CONCLUSIONS: Postoperative AF (POAF) exists as a rare complication in women who undergo CD with an incidence of 0.04% in our patient population. All parturients in our study were noted to have hypomagnesemia in the postoperative period. Occurrence of AF increased length of hospital stay and utilization of hospital resources.

Entities:  

Keywords:  cesarean delivery; postoperative atrial fibrillation

Year:  2018        PMID: 30393767      PMCID: PMC6211611          DOI: 10.21454/rjaic.7518.252.klv

Source DB:  PubMed          Journal:  Rom J Anaesth Intensive Care        ISSN: 2392-7518


  26 in total

Review 1.  The increasing cesarean rate globally and what we can do about it.

Authors:  Y Niino
Journal:  Biosci Trends       Date:  2011-08       Impact factor: 2.400

Review 2.  Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications.

Authors:  Srikanth Vallurupalli; Anusha Shanbhag; Jawahar L Mehta
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

3.  Risk of stroke in non-rheumatic atrial fibrillation.

Authors:  K M Flegel; M J Shipley; G Rose
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

4.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

5.  Serum magnesium levels in pregnancy and preterm labor.

Authors:  R B Kurzel
Journal:  Am J Perinatol       Date:  1991-03       Impact factor: 1.862

6.  Postoperative atrial fibrillation in noncardiothoracic surgical patients.

Authors:  K K Christians; B Wu; E J Quebbeman; K J Brasel
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

7.  Cesarean delivery rates vary tenfold among US hospitals; reducing variation may address quality and cost issues.

Authors:  Katy Backes Kozhimannil; Michael R Law; Beth A Virnig
Journal:  Health Aff (Millwood)       Date:  2013-03       Impact factor: 6.301

8.  Supraventricular tachycardia in pregnancy.

Authors:  K Robins; G Lyons
Journal:  Br J Anaesth       Date:  2004-01       Impact factor: 9.166

Review 9.  Sex Differences in Atrial Fibrillation.

Authors:  Jason G Andrade; Marc W Deyell; Andrea Y K Lee; Laurent Macle
Journal:  Can J Cardiol       Date:  2017-12-06       Impact factor: 5.223

Review 10.  Arrhythmias in the pregnant patient: current concepts in evaluation and management.

Authors:  Jordana Kron; Jamie B Conti
Journal:  J Interv Card Electrophysiol       Date:  2007-08-09       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.